Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
GABBR2 Polyclonal Antibody, Invitrogen™
Rabbit Polyclonal Antibody
Supplier: Thermo Scientific PA528340
Description
Recommended positive controls: U87-MG, unboiled Myc-DDK-tagged Gabbr2-transfected 293T. Predicted reactivity: Mouse (97%), Rat (96%). Store product as a concentrated solution. Centrifuge briefly prior to opening the vial.
GABBR2 Polyclonal antibody specifically detects GABBR2 in Human, Rat samples. It is validated for Immunohistochemistry (Frozen), Western Blot.Specifications
GABBR2 | |
Polyclonal | |
Unconjugated | |
GABBR2 | |
FLJ36928; G protein-coupled receptor 51; GABA BR; GABA-B R2 receptor; GABA-B receptor 2; GABA-B receptor, R2 subunit; GABABR2; GABA-BR2; GABA-B-R2; Gabbr2; gamma-aminobutyric acid; gamma-aminobutyric acid (GABA) B receptor 2; gamma-aminobutyric acid (GABA) B receptor, 2; gamma-aminobutyric acid B receptor 2; gamma-aminobutyric acid type B receptor subunit 2; gamma-aminobutyric acid type B receptor, subunit 2; gb2; Gm425; Gpr51; GPRC3B; G-protein coupled receptor 51; HG20; HRIHFB2099; MGC119386; MGC119388; MGC119389; ortholog of human G protein-coupled receptor 51 GPR51; RP23-337N2.1 | |
Rabbit | |
Antigen affinity chromatography | |
RUO | |
83633, 9568 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
Immunohistochemistry (Frozen), Western Blot | |
0.83 mg/mL | |
0.1M tris glycine with 20% glycerol and 0.01% thimerosal; pH 7 | |
O75899, O88871 | |
GABBR2 | |
Recombinant fragment corresponding to a region within amino acids 163 and 516 of Human GABA B Receptor 2 | |
100 μL | |
Primary | |
Human, Rat | |
Antibody | |
IgG |
Provide Content Correction
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?
Provide Content Correction